Back
INVO Fertility Inc (IVF) Earnings
IVF Stock Price Chart
IVF Earnings
INVO Fertility Inc
$0.69
-0.02%
$0
At close: Mar 23, 16:00:00 GMT-4
$0.71
3%
$0.02
Pre-market: Mar 24, 04:39:07 GMT-4
Latest Earnings Results: Q3 '25
Reported: 2025-11-17
Historical Earnings
Quarterly
Annual
EPS
Revenue
Earnings FAQ
How did IVF's recent EPS compare to expectations?
How did INVO Fertility Inc IVF's revenue perform in the last quarter?
What is the revenue estimate for INVO Fertility Inc?
What's the earning quality score for INVO Fertility Inc?
When does INVO Fertility Inc report earnings?
What are INVO Fertility Inc's expected earnings?
Did INVO Fertility Inc beat earnings expectations?
Key Stats
Prev.Close
$0.6902
Open
$0.6667
Day's Range
$0.66 - $0.7107
52 week range
$0.6803 - $76.8
Volume
96.5K
Avg.Volume
5.0M
Dividend yield
--
EPS (TTM)
-440.26
Market Cap
$4.9M
What is IVF?
INVO Fertility, Inc. operates as a revenue-generating fertility business. The company is headquartered in Sarasota, Florida and currently employs 28 full-time employees. The company went IPO on 2008-11-11. Its segments include Fertility Clinic Services, INVOcell Device, and Therapeutics. The company focuses on operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, in vitro fertilization (IVF) clinics. The company has two operational INVO Centers in the United States and one IVF clinic. The company is also engaged in the sale and distribution of its INVOcell technology solution to third party-owned and operated fertility clinics. The INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a natural, intimate, and affordable experience.
Features
Resources
© 2026 Finture Development Limited. All rights reserved